BizInt Solutions

Since 1996, BizInt Smart Charts software has helped analysts create reports and visualizations from drug pipeline, clinical trial, patents and IP sequence data.

[BizInt Solutions @BizIntSmartChts]

Sitting down for the plenary session at the 2023 PIUG Biotechnology Conference

[BizInt Solutions @BizIntSmartChts]

Proud to see Diane inducted to the PHT Hall of Phame!

[BizInt Solutions @BizIntSmartChts]

Thanks for sharing our 25th anniversary cake and champagne at the PHT meeting!

[BizInt Solutions @BizIntSmartChts]

Happy to see so many customers and partners at the SLA PHT meeting in Philadelphia.

[BizInt Solutions @BizIntSmartChts]

Back in the saddle again - see everyone at #PIUG22

[BizInt Solutions @BizIntSmartChts]

Join us tomorrow for a free webinar (presented by SLA DPHT) as Matt and Diane share technical details and lessons learned from our COVID-19 vaccine landscape.

Register at https://t.co/pm2Wlotcln

[BizInt Solutions @BizIntSmartChts]

We've been burning the midnight oil the last two weeks, but Version 5.3 of the BizInt Smart Charts Drug Development Suite is ready, introducing support for GlobalData.

Learn more at https://t.co/n2osWAN4aN

[BizInt Solutions @BizIntSmartChts]

We've been so busy getting the next release of the Drug Development Suite ready that we forgot to tweet this week's update!

Lots of activity in the COVID vaccine landscape - see all the details at https://t.co/nxSnzS7jqk including geographic details in a piano chart

[BizInt Solutions @BizIntSmartChts]

Drug pipeline databases have a lot more structured detail which allows us to slice and dice the COVID-19 vaccine landscape. Here are vaccines not in development in the US, UK, and Europe. See https://t.co/iBok9D4D2q for more

[BizInt Solutions @BizIntSmartChts]

This update of our COVID-19 Vaccine Landscape is a reset of the process. We are now using commercial drug pipelines data rather than public trial registry data - we will be refining the presentation over the coming weeks.

https://t.co/nxSnzS7jqk

[BizInt Solutions @BizIntSmartChts]

Our latest COVID-19 vaccine landscape doesn't show a lot of change from the last update. However we expect to see quite a bit of activity in the coming weeks.

https://t.co/nxSnzS7jqk

[BizInt Solutions @BizIntSmartChts]

The first 2021 update of our COVID-19 Vaccine development landscape is now available at https://t.co/iBok9DmdTY

[BizInt Solutions @BizIntSmartChts]

Our final COVID-19 vaccine landscape of 2020, showing Moderna's vaccine joining BioNTech/Pfizer with authorizations. Still a lot of work being done - see the whole picture at https://t.co/iBok9DmdTY

[BizInt Solutions @BizIntSmartChts]

The pace of development of a COVID-19 vaccine has been incredible. This summer we shared our first bullseye and with this update the first vaccine has been issued an EUA.

See the other vaccines on the horizon at https://t.co/nxSnzS7jqk

[BizInt Solutions @BizIntSmartChts]

How it started... How it's going...

[BizInt Solutions @BizIntSmartChts]

The type of news that sadly stretches the timeline for 2021. In an explanatory timeline, how do we represent this? Stretch the bar for the trial? Move milestones?

[Helen Branswell 🇨🇦 @HelenBranswell]

There has been some great news on #Covid19 vaccine trials but this kind of ends that streak. Sanofi runs into a problem that sets back one of the world’s largest vaccine producers — and every country that hoped to buy from them. https://t.co/jz9WvBeMG1

[BizInt Solutions @BizIntSmartChts]

The latest update of our COVID-19 vaccine bullseye is up. Here we zoom in on technology areas with a lot of activity, but there are changes all over the landscape including several more vaccines starting Phase 3 trials.

See the complete picture at https://t.co/nxSnzS7jqk

[BizInt Solutions @BizIntSmartChts]

We've changed the center of our bullseye - rather than "Launched", we now use the term "Authorized" to include both FDA Emergency Use Authorization (EUA) and EMA Conditional Marketing Authorisation (CMA).

[BizInt Solutions @BizIntSmartChts]

The latest update to our COVID-19 vaccine bullseye is available at https://t.co/nxSnzS7jqk, including the first live-attenuated vaccine.

A new glyph highlights programs (currently BioNTech/Pfizer and Moderna) reporting Phase 3 efficacy data.

[BizInt Solutions @BizIntSmartChts]

New vaccines for COVID-19 continue to register trials at https://t.co/R9adiNAU1Z, as shown on the latest update of our COVID-19 Vaccine Bullseye. Learn more at https://t.co/nxSnzS7jqk